Feasibility Pilot Study of OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2018
At a glance
- Drugs Disufenton (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 25 Sep 2018 Status changed from not yet recruiting to recruiting.
- 27 Aug 2018 Planned initiation date changed from 30 Jul 2018 to 1 Oct 2018.
- 18 Jul 2018 New trial record